Article
Molecular diagnostics in acute leukemias
1 Jan 2009
Abstract excerpt
Acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) both represent highly heterogeneous entities on the basis of diverse cyto- and molecular genetic alterations with considerable influence on prognosis and therapeutic decisions. In recent years, insights into the complex network of molecular markers underlying this diversity have shown marked progress due to the detection of novel mutations, such...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
